News

Takeda selects five new partnerships for annual CSR program

Takeda's Global CSR Programmakes multi-year commitments in partnership with key global stakeholders. The Program is rooted in the company’s patient-centricity and dedication to disease prevention.

Jun 28, 2019

By : Team ABLE

Innovations like CRISPR-Cas9 to offer effective disease management and drive the genomics market: IndustryaArc

Progressive gene editing procedures such as CRISPR-Cas9 may offer new approaches for modification of genes to treat erratic genetic diseases.

Jun 28, 2019

By : Team ABLE

Immunome appoints Purnanand Sarma as President and CEO

Prior to joining Immunome, Sarma was the President & CEO of Taris Biomedical.

Jun 28, 2019

By : Team ABLE

Hilleman Laboratories licenses Oral Cholera Vaccine Hillchol to Bharat Biotech

The collaboration between the companies seeks to acceleratethe development, licensure, manufacture and supply of an affordable, next-generation Cholera vaccine.

Jun 27, 2019

By : Team ABLE

NITI Aayog Healthy States Progressive India Report: Kerala, AP & Maharashtra ranked top in overall performance

The report has been developed by NITI Aayog, with technical assistance from the World Bank, and in consultation with the Ministry of Health and Family Welfare (MoHFW).

Jun 26, 2019

By : Team ABLE